Publications by authors named "Massimo Zuin"

Claim this Profile
A
Adherence, satisfaction, and quality of life in Wilson disease patients after switching to trientine tetrahydrochloride: observational data from a dual cohort study.
Valentina Medici, Nora Cazzagon, Pier M Battezzati, Andrea Crosignani, Alberto Civolani, Massimo Zuin

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Economic Burden, Epidemiological Insights, and Treatment Patterns of Wilson's Disease: A Real-World Study in Italy.
Paolo Sciattella, Matteo Scortichini, Nora Cazzagon, Georgios Loudianos, Massimo Zuin

Drugs Real World Outcomes· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative management practices of Wilson disease in Californian and Italian providers.
Sandy Vien, Colin McNamara, Ronald Hsu, Massimo Zuin, Valentina Medici

J Health Popul Nutr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-up.
Monica Bignotto, Elena Bianco, Lucia Centofanti, Antonio Russo, Michele Dei Cas, Massimo Zuin

Am J Physiol Endocrinol Metab· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets.
Peter Ott, Thomas Sandahl, Aftab Ala, David Cassiman, Eduardo Couchonnal-Bedoya, Massimo Zuin

JHEP Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Michael L Schilsky, Anna Czlonkowska, Massimo Zuin, David Cassiman, Carlos Twardowschy

Lancet Gastroenterol Hepatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
Antonio De Vincentis, Daphne D'Amato, Laura Cristoferi, Alessio Gerussi, Federica Malinverno, Massimo Zuin

Liver Int· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d -penicillamine.
Karl Heinz Weiss, Carlot Kruse, Nina Manolaki, Massimo Zuin, Peter Ferenci

Eur J Gastroenterol Hepatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis.
Alessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, Willem J Lammers, Henk Van Buuren, Massimo Giovanni Zuin

Clin Gastroenterol Hepatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study.
Nicola Pugliese, Alessia Giorgini, Daniela Maggi, Antonio Capogreco, Clara Dibenedetto, Massimo Zuin

Expert Opin Drug Saf· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CA.ME.LI.A. An epidemiological study on the prevalence of CArdiovascular, MEtabolic, LIver and Autoimmune diseases in Northern Italy.
Monica Bignotto, Michele Dei Cas, Rita Paroni, Elena Bianco, Paola Zermiani, Massimo Zuin

Nutr Metab Cardiovasc Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Many Faces of Covid-19 at a Glance: A University Hospital Multidisciplinary Account From Milan, Italy.
Alberto Priori, Alessandro Baisi, Giuseppe Banderali, Federico Biglioli, Gaetano Bulfamante, Massimo Zuin

Front Public Health· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort.
Maria Giovanna Quaranta, Luigina Ferrigno, Monica Monti, Roberto Filomia, Elisa Biliotti, Massimo Zuin

Hepatol Int· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic thermoablation for hepatocellular carcinoma in patients with liver cirrhosis: an effective procedure for tricky tumors.
Roberto Santambrogio, Matteo Barabino, Valentina D'Alessandro, Elisa Galfrascoli, Marco Antonio Zappa, Massimo Zuin

Med Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population.
Carlo Selmi, Maria De Santis, Pier Maria Battezzati, Elena Generali, Simone Aldo Lari, Massimo Zuin

Int J Cardiol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study.
Roberta D'Ambrosio, Luisa Pasulo, Alessia Giorgini, Angiola Spinetti, Emanuela Messina, Massimo Zuin

Dig Liver Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study on analytical characteristics of Nicotiana tabacum L., cv. Solaris biomass for potential uses in nutrition and biomethane production.
Antonella Fatica, Francesco Di Lucia, Stefano Marino, Arturo Alvino, Massimo Zuin

Sci Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
Loreta A Kondili, Sarah Robbins, Sarah Blach, Ivane Gamkrelidze, Anna L Zignego, Massimo Zuin

Liver Int· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver toxicity in the era of immune checkpoint inhibitors: A practical approach.
Carmen Belli, Massimo Zuin, Luca Mazzarella, Dario Trapani, Paolo D'Amico

Crit Rev Oncol Hematol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Francesco Bifari, Roberto Manfrini, Michele Dei Cas, Cesare Berra, Matteo Siano, Massimo Zuin

Pharmacol Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.
Marco Carbone, Alessandra Nardi, Steve Flack, Guido Carpino, Nikoletta Varvaropoulou, Massimo Zuin

Lancet Gastroenterol Hepatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in Southern Italy.
Carmelo Antonio Caserta, Alfonso Mele, Pasquale Surace, Luigina Ferrigno, Angela Amante, Massimo Zuin

Ann Ist Super Sanita· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
Rosanna Squitti, Roberta Ghidoni, Ilaria Simonelli, Irena D Ivanova, Nicola Antonio Colabufo, Massimo Zuin

J Trace Elem Med Biol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort.
Loreta A Kondili, Federica Romano, Francesca Romana Rolli, Matteo Ruggeri, Stefano Rosato, Massimo Zuin

Hepatology· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Dario Degiorgio, Andrea Crosignani, Carla Colombo, Domenico Bordo, Massimo Zuin

J Gastroenterol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis